Clinical Trial Transparency & Disclosure

Vendor and Partner Oversight Considerations for Global Registry Harmonization Global registry harmonization stands as a critical element in promoting transparency and efficiency in clinical trials. With the increasing complexity of regulatory requirements across the US, UK, and EU, organizations like Sarah Cannon Clinical Trials have taken significant strides to align their strategies with global best…

Read More “Vendor and Partner Oversight Considerations for Global Registry Harmonization” »

Future Trends: AI, Real-World Data and Evolving Rules for Global Registry Harmonization The landscape of clinical trials has been evolving rapidly, significantly influenced by advancements in technology, regulatory changes, and the rising emphasis on transparency and data sharing. This comprehensive tutorial aims to discuss the future trends impacting global registry harmonization, particularly in the context…

Read More “Future Trends: AI, Real-World Data and Evolving Rules for Global Registry Harmonization” »

Using Global Registry Harmonization to Support Publications, HTA and Market Access Using Global Registry Harmonization to Support Publications, HTA and Market Access In the dynamic landscape of clinical research, the importance of effective data management and transparency in clinical trials cannot be overstated. Global Registry Harmonization plays a pivotal role in enhancing the quality and…

Read More “Using Global Registry Harmonization to Support Publications, HTA and Market Access” »